Story of Chugai
Stories
A Story of Paving the Way to the Future,
Thinking
of Patients' Happiness
So many people around the world still suffer from diseases that have no cure.
Chugai aims to deliver effective treatments and services through the power of innovation, with the goal of bringing happiness to patients.
To achieve this, each employee pursues the creation of continuous innovation with fresh ideas that are not bound by conventional wisdom.
Realizing advanced and sustainable patient-centric healthcare.
We present to you the story of our employees' challenges as they forge ahead on uncharted paths, always keeping in mind the happiness of patients that lies beyond.
PICK UP
Oct 07, 2025
The immune system protects the body from harm. In this process, regulatory T cells act as regulators or brakes suppressing excessive immune responses. A recent
- Innovation
- R&D
Mar 06, 2025
The Chugai Pharmaceutical Group considers global environmental protection to be an important foundation for all its business activities, and has set three
- Global Environment
- Supply Chain Management
Display Conditions
-
Pharmaceutical Development Accelerated with Real-world data (RWD) - Taking on the Challenge of Developing Acute-phase Therapeutic Drugs in Collaboration with MeDiCU, Inc.
Chugai Pharmaceutical utilizes real-world data (RWD)* for increased efficiency and advancement in the clinical development of new drugs, verification of drug
- R&D
- DX
- External Experts
-
Creating and Expanding Regulatory T cells: The Possibility of Cellular Therapy Explored by a Joint Research Team from Chugai and the Immunology Frontier Research Center (IFReC), the University of Osaka
The immune system protects the body from harm. In this process, regulatory T cells act as regulators or brakes suppressing excessive immune responses. A recent
- Innovation
- R&D
-
Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals
Chugai Pharmaceutical is currently promoting companywide DX to achieve the targets of its new growth strategy Top I 2030. The company is focusing on innovative
- Innovation
- R&D
- DX
- Sustainability
- CHUGAI DIGITAL VISION 2030
- Production Technology
-
Working to Reform the Drug Discovery Process—Acceleration of Drug Discovery Research Using Cryo-EM
Torizawa is general manager of the Protein Science Research Department. He is currently in charge of the early stages of drug discovery to uncover molecules
- Innovation
- R&D
- Recruitment
- Research
- Cryo-Electron Microscopy
-
Working Toward Greater Efficiency in the Drug Discovery Process for Mid-size Molecules. Development of a Crystallization Confirmation App Using Agile Development Methods
Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and
- Innovation
- R&D
- DX
- Mid-Molecule Pharmaceuticals
-
Next-generation pharmaceutical lead by digital technology Taking on innovative drug development with a data-driven approach
The Pharmaceutical Technology Division is in charge of the development process leading to the commercialization of candidate molecules. Within that division,
- R&D
- DX
- Recruitment
- Research
- Drug Discovery Modalities
- Production Technology
-
From the medical frontlines to a pharmaceutical company. Medical doctors leveraging their clinical experience to contribute to the creation of pharmaceuticals
Chugai Pharmaceutical, with its R&D bases and global development functions in Japan, has strived to conduct clinical studies based on medical grounds and
- Innovation
- R&D
- Recruitment
- Human Resources
- Medical Doctor
-
To become a top runner in drug production. Taking on the challenge of innovative drug manufacturing with next-generation manufacturing facilities
Chugai Pharmaceutical’s bio drug substance (DS) manufacturing facility “UK4,” which contributes to the realization of sustainable global
- R&D
- Recruitment
- Sustainability
- Supply Chain Management
- Drug Discovery Modalities
- Production Technology
-
Maximizing Drug Discovery Through Team Capabilities. Delivering Innovative Drugs to Patients with Process and Technological Development
Kondo is an employee at the pharmaceutical research department. Within his group, in addition to overseeing process development and manufacturing technology
- Innovation
- R&D
- DX
- Recruitment
- Mid-Molecule Pharmaceuticals
- Production Technology
-
The future of drug discovery opened up by a research environment with a high degree of freedom. Using diverse modalities to create innovative pharmaceuticals
Chugai Pharmaceutical’s strengths lie in its world-leading antibody drug discovery technologies and advanced small-molecule drug discovery research. The
- Innovation
- R&D
- Recruitment
- Research
- Drug Discovery Modalities
- Production Technology